Already a Member? Login

Interim data from NHLBI examining 3 international trials suggesting decreased morbidity and  mortality for COVID-19 patients with therapeutic anticoagulation for patients not in the ICU.  Please share this important summary. IT CAN SAVE LIVES.
VIEW ARTICLE
ATTACC, REMAP-CAP, and ACTIV-4 Logos